Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Sierra Oncology, Inc. (SRRA)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   10-K10-K10-K10-K10-K10-K10-K10-K
Operating expenses:          
Research and development  67.245.153.241.130.233.926.419.1
General and administrative  27.420.113.714.312.514.29.53.5
    Total operating expenses  94.665.267.055.442.648.135.822.6
    Loss from operations  -94.6-64.9-67.0-55.4-42.6-48.1-35.8-22.6
Other expense, net  -0.10.4-0.51.80.80.40.10.1
    Loss before provision for (benefit from) income taxes, net  -94.7-80.8-88.4-53.6-41.9-47.7-53.2-23.9
Provision for (benefit from) income taxes, net  0.00.1-0.2-0.30.20.10.10.0
    Net loss and comprehensive loss  -94.7-80.9-88.3-53.3-42.0-47.9-53.3-23.9
   
Net loss per common share, basic and diluted  ($7.14)($7.70)($30.30)($30.16)($33.68)($1.58)($31.47)($69.08)
   
Weighted-average shares used in computing net loss per common share, basic and diluted  13.310.52.91.81.230.214.41.1

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy